CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 439 filers reported holding CRISPR THERAPEUTICS AG in Q2 2022. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $353,180 | -29.3% | 7,781 | -12.6% | 0.01% | -66.7% |
| Q2 2023 | $499,814 | +11.8% | 8,903 | -9.9% | 0.04% | +5.9% |
| Q1 2023 | $446,912 | +17.8% | 9,880 | +5.8% | 0.03% | +9.7% |
| Q4 2022 | $379,427 | -52.2% | 9,334 | -23.2% | 0.03% | -58.7% |
| Q3 2022 | $794,000 | -7.2% | 12,149 | -13.7% | 0.08% | -5.1% |
| Q2 2022 | $856,000 | +5.5% | 14,078 | +9.0% | 0.08% | +25.4% |
| Q1 2022 | $811,000 | -33.0% | 12,919 | -19.2% | 0.06% | -28.4% |
| Q4 2021 | $1,211,000 | – | 15,987 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
| NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
| ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
| Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
| CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
| Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
| HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
| Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
| EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |